0001437749-15-009010.txt : 20150505 0001437749-15-009010.hdr.sgml : 20150505 20150505173524 ACCESSION NUMBER: 0001437749-15-009010 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150501 FILED AS OF DATE: 20150505 DATE AS OF CHANGE: 20150505 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HYPERION THERAPEUTICS INC CENTRAL INDEX KEY: 0001386858 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 611512713 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 BUSINESS PHONE: 650-745-7802 MAIL ADDRESS: STREET 1: 2000 SIERRA POINT PARKWAY STREET 2: SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Nash Christine A CENTRAL INDEX KEY: 0001554403 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35614 FILM NUMBER: 15834293 MAIL ADDRESS: STREET 1: C/O HYPERION THERAPEUTICS, INC. STREET 2: 2000 SIERRA POINT PARKWAY, SUITE 400 CITY: BRISBANE STATE: CA ZIP: 94005 4 1 rdgdoc.xml FORM 4 X0306 4 2015-05-01 0001386858 HYPERION THERAPEUTICS INC HPTX 0001554403 Nash Christine A C/O HYPERION THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 400 BRISBANE CA 94005 1 SVP & Chief Commercial Officer Common Stock 2015-05-01 4 M 0 16157 1.28 A 53160 D Common Stock 2015-05-01 4 M 0 12709 4.08 A 65869 D Common Stock 2015-05-01 4 M 0 30221 7.31 A 96090 D Employee Stock Option (right to buy) 1.28 2015-05-01 4 M 0 16157 0 D 2020-04-14 Common Stock 16157 0 D Employee Stock Option (right to buy) 4.08 2015-05-01 4 M 0 12709 0 D 2021-04-14 Common Stock 12709 0 D Employee Stock Option (right to buy) 7.31 2015-05-01 4 M 0 30221 0 D 2022-04-15 Common Stock 30221 6881 D This option was vested and exercisable on date of exercise. /s/ Sally Brammell, Attorney-in-fact 2015-05-05